Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Autologous Hematopoietic Stem Cell Transplantation”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableWithdrawnNCT01454687
What this trial is testing

Grafting of Epidermolysis Bullosa Wounds Using Cultured Revertant Autologous Keratinocytes

Who this might be right for
Epidermolysis Bullosa
Stanford University
Early research (Phase 1)Active Not RecruitingNCT02311621
What this trial is testing

Engineered Neuroblastoma Cellular Immunotherapy (ENCIT)-01

Who this might be right for
NeuroblastomaGanglioneuroblastoma
Seattle Children's Hospital 65
Large-scale testing (Phase 3)Looking for participantsNCT07112443
What this trial is testing

Assess How Effective and Safe NVD003 is for Treating Patients With Congenital Pseudarthrosis of the Tibia.

Who this might be right for
Congenital Pseudarthrosis of Tibia
Novadip Biosciences 12
Testing effectiveness (Phase 2)Study completedNCT01523834
What this trial is testing

Oral Panobinostat Adult Patients DLBCL Relapsed/Refractory Stem Cell Transfusion (ASCT) or Not Eligible for ASCT

Who this might be right for
Diffuse Large B-cell Lymphoma
Fondazione Italiana Linfomi - ETS 35
Very early researchUnknownNCT04186052
What this trial is testing

Clinical Trial of BCMA CAR T Cell Infusion in Patients With BCMA-positive r/r Multiple Myeloma

Who this might be right for
Multiple Myeloma
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 10
Early research (Phase 1)UnknownNCT03840317
What this trial is testing

Senl_1904A and Senl_1904B Chimeric Antigen Receptor （CAR） T-Cell in the Treatment of r/ r Acute B Lymphocytic Leukemia

Who this might be right for
Acute Lymphocytic Leukemia
Hebei Senlang Biotechnology Inc., Ltd. 20
Testing effectiveness (Phase 2)Study completedNCT01865617
What this trial is testing

Laboratory Treated T Cells in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma, or Acute Lymphoblastic Leukemia

Who this might be right for
CD19-Positive Neoplastic Cells PresentRecurrent Adult Acute Lymphoblastic LeukemiaRecurrent Chronic Lymphocytic Leukemia+10 more
Fred Hutchinson Cancer Center 204
Not applicableStudy completedNCT02138890
What this trial is testing

APSS-33-00: A Multicenter, Pilot Study of Autologous Protein Solution (APS) in Knee Osteoarthritis (OA)

Who this might be right for
Osteoarthritis, Knee
Zimmer Biomet 46
Not applicableUnknownNCT03704597
What this trial is testing

Cryotherapy Against Oral Mucositis After High-dose Melphalan

Who this might be right for
MyelomaMucositisCryotherapy Effect
Sahlgrenska University Hospital 100
Early research (Phase 1)Active Not RecruitingNCT02808208
What this trial is testing

Autologous Adipose Derived Mesenchymal Stem Cells (AMSC) in Reducing Hemodialysis Arteriovenous Fistula Failure

Who this might be right for
End Stage Renal Disease (ESRD)Vascular Access Complication
Mayo Clinic 74
Early research (Phase 1)Study completedNCT00313508
What this trial is testing

Dendritic Cell Vaccination During Lymphoid Reconstruction

Who this might be right for
Intraocular MelanomaMelanoma (Skin)
H. Lee Moffitt Cancer Center and Research Institute 18
Testing effectiveness (Phase 2)Study completedNCT01719640
What this trial is testing

MSC and MC in Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
Fuzhou General Hospital 22
Testing effectiveness (Phase 2)Study completedNCT03322917
What this trial is testing

Ocular Surface Syndrome Post-lasik, Outcomes of Treatment With Platelet Rich Plasma

Who this might be right for
Dry Eye After LASIK-Laser in Situ Keratomileusis
Vissum, Instituto Oftalmológico de Alicante 80
Testing effectiveness (Phase 2)Study completedNCT00899847
What this trial is testing

Phase 2 Study of Autologous Followed by Nonmyeloablative Allogeneic Transplantation Using TLI & ATG

Who this might be right for
Transplantation, HomologousTransplantation, AutologousMultiple Myeloma+1 more
Stanford University 9
Testing effectiveness (Phase 2)Study completedNCT00019097
What this trial is testing

Vaccine Therapy in Treating Patients With Multiple Myeloma

Who this might be right for
Stage II Multiple MyelomaStage III Multiple MyelomaRefractory Plasma Cell Neoplasm
National Cancer Institute (NCI)
Large-scale testing (Phase 3)UnknownNCT00002455
What this trial is testing

Immunotherapy After Surgery in Treating Patients With Breast Cancer, Colon Cancer, or Melanoma

Who this might be right for
Breast CancerColorectal CancerMelanoma (Skin)
Centro Oncologico de Excelencia
Not applicableEnded earlyNCT03585855
What this trial is testing

Mesenchymal Stem Cell Transplantation in the Treatment of Chronic Antibody Mediated Kidney Graft Rejection (ABMR)

Who this might be right for
Interventional
University Medical Centre Ljubljana 4
Testing effectiveness (Phase 2)Study completedNCT00850252
What this trial is testing

Use of a Lifeline Graft in the A-V Shunt Model

Who this might be right for
ESRDHemodialysis
Cytograft Tissue Engineering
Not applicableStudy completedNCT03234335
What this trial is testing

High Dose Therapy Followed by Autologous Transplantation for Myeloma Patients With Severe Renal Impairment

Who this might be right for
Multiple MyelomaRenal Failure
Centre Hospitalier Universitaire de Saint Etienne 50
Testing effectiveness (Phase 2)Study completedNCT00014508
What this trial is testing

Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Eastern Cooperative Oncology Group
Next Page